Noreen brings over 27 years’ global clinical development experience covering all phases in a broad range of therapeutic areas in both the Pharmaceutical and CRO industries. Prior to joining Biodexa Pharmaceuticals, she has successfully led an oncology registrational phase III study to completion delivering positive results that supported a regulatory submission. She has also held senior management positions in various CRO’s supporting clients to develop and execute strategic clinical programs.

Noreen studied Biomedical Sciences and holds a PMP qualification.